top of page


Cancer52 meets with Minister for Cancer
Interim CEO, Sasha Daly was pleased to meet with Minister Andrew Gwynne to talk through cancer services and how Cancer52 can work in partner


New CEO for Cancer52!
Cancer52 is delighted to announce the appointment of Chris Walden as our new CEO.


Cancer52's Manifesto 'The Other Half'
Cancer52 has launched a manifesto called  ‘The Other Half. A manifesto to transform outcomes for people with rare and less common...


Big Cancer52 Conversation, 19th June 2024
Cancer52 recently hosted The Big Cancer52 Conversation at Level39 in Canary Wharf. This was the third Big Cancer52 Conversation, and...


The Ella Dawson Foundation joins Cancer52
The Ella Dawson Foundation is the newest member of Cancer52! The Ella Dawson Foundation provides psychological, emotional, physical,...


Cancer52's newest member - The Young Tongues
Cancer52 are delighted to welcome The Young Tongues as the latest member to join Cancer52. The Young Tongues provide peer-to-peer support...


Cancer52 analysis on rare and less common cancer research spend
Cancer52 and the National Cancer Research Institute (NCRI) joined forces to create a report titled: Research into rare and less common...


Annual Review 2020-21
Cancer52 is delighted to present its Annual Review 2020-21. This report particularly highlights the strength and impact of Cancer52’s...


2021 All Stakeholder Briefing
On Wednesday 13th October, we hosted our Annual All Stakeholder Briefing, focusing on Early diagnosis for rare and less common cancers:...


Cancer52 Patient Survey Results - July 2020
We are pleased to share the results of the survey into the impact of Covid-19 on people with rare and less common cancers. The report is...
bottom of page